Диагностическое и прогностическое значение тропонина, мозгового натрийуретического пептида и высокочувствительного С — реактивного белка при остром коронарном синдроме
Диссертация
При проведении клинических и эпидемиологических исследований была выявлена связь между тяжестью систолической и диастолической дисфункции миокарда левого желудочка и содержанием натрийуретических пептидов в плазме, что позволило рассматривать определение концентрации. 8' ' этих пептидов: в качестве «лабораторного теста» GH: Натрийуретические пептиды были подробно изучены при СН, асимптоматической… Читать ещё >
Список литературы
- Беленков Ю.Н., Васюк Ю. А., Галявич А. С. и соавт. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (второй пересмотр). // Сердечная Недостаточность. — 2007. № 8 (2). — С. 1−35
- Бельков В.В. С-реактивный белок «золотой маркер», многозначительный и незаменимый // Кардиолог: научночпрактический рецензируемый журнал. 2006. — № 2. — С. 69−80
- Вельков В.В. С-реактивный белок в лабораторной' диагностике острых воспалений и в оценке рисков сосудистых патологий. // Клинико-лабораторный консилиум. — 2008. — № 2(21). — С. 37−48'
- Диагностика и лечение больных острым инфарктом миокарда с подъемом сегмента ST электрокардиограммы. Рекомендации Всероссийского научного общества кардиологов. // Кардиоваскулярная терапия и профилактика. — 2007. № 6 (8). -Приложение 1.
- Лечение острого коронарного синдрома без стойкого подъема сегмента ST на ЭКГ. Российские рекомендации.1 Всероссийское научное общество кардиологов. // Consilium-Medicum. 2001. -№ 10(3).- С. 1−32
- Насонов Е.Л., Панюкова Е.В., Александрова Е. Н. С-реактивный белок маркер воспаления при атеросклерозе (новые данные). // Кардиология. — 2002. — № 7. — С. 53−62
- Олефиренко Г. А., Чиликина Г. В., Шевченко О. П. Применение С-реактивного белка в лабораторной практике. В сб.: Лабораторная диагностика. М.: Издательство «Реафарм», 2005. — С. 144−146
- Тифонов И.Р. Биохимические маркеры некроза миокарда// Кардиология. 2001. — № 10,12. — С. 93−97, 84−88
- Adams III J.E., Davila-Roman V.G., Bessey P.Q., et al. Improveddetection of cardiac contusion with cardiac troponin 1.1 I Am Heart J. -1996.-Vol. 131.-P. 308−312
- Allan S., Jaffe M.D., Babuin L., Apple F. Biomarkers in Acute Cardiac Disease: the Present and the Future. // Journal of the American College of Cardiology. 2006. — Vol. 48. — P. 1−11
- Antman E.M. Decision making with cardiac troponin tests. // N Engl J Med. 2002. — Vol. 346. — P. 2079- 2082
- Anzai Т., Yoshikawa Т., Shiraki H., Asakura Y., Akaishi M., Mitamura H., Ogawa S. C-Reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. // Circulation 1997. — Vol. 96. — P. 778−784
- Apple F.S. Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB. // Clin Chim Acta. 1999. — Vol. 284. — P. 151−159
- Apple F.S., Murakami M.M. Cardiac troponin and creatine kinase MB monitoring during in-hospital myocardial reinfarction. // Clin Chem. -2005. Vol. 51. — P. 460−463
- ATS Statement: Guidelines for the six-minute walk test. // Am J Respir Crit Care Med. 2002. — Vol. 166. — P. 111−117
- Bassan R. et coll. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. // Eur Heart J. 2005. — Vol. 26. — P. 234−240
- Bianciotti L.G., de Bold A.J. Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension. // Cardiovascular research. — 2001. Vol. 49.-P. 808−16
- Braunwald E. Braunwald’s Heart Diseases: A Textbook of Cardiovascular Medicine, 8th edition. // Saunders, An Imprint of Elsevier. 2007.
- Braunwald E., Hamm C.W. A classification of Unstable Angma Revisited. // Circulation. 2000. — Vol. 102. — P. 118−122
- Burke A.P., Tracy R.P., Kolodgie F., et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. // Circulation. 2002. — Vol. 105. — P. 2019−23
- Bursi F., Weston A., Killian M., Gabriel E., Jacobsen J., et al. C-Reactive Protein and Heart Failure after Myocardial Infarction in the Community. // The American Journal of Medicine. 2007. — Vol. 120. -P. 616−622
- Chatha K., Alsoud M., Griffiths M.J., et al. B-type natriuretic peptide in reversible myocardial ischaemia. // J Clin Pathol. 2006. — Vol. 59 (11). -P. 1216−7
- Cheng V., Kazanegra R., Garcia A., et al. A rapid bedside test for B-type peptide predicts treatment outcomes in* patients admitted for decompensated heart failure: a pilot study. // J Am Coll Cardiol. 2001. -Vol. 37.-P. 386−391
- Conen D., Jander N., Trenk D., Neumann F.J., Mueller C. The use of B-type natriuretic peptide in detection of myocardial ischemia in settings with rapid access to coronary angiography. // Int J Cardiol. 2007. -Vol. 119(3).-P. 416−8
- Cook D.C., Mendall M.A., Whincup P.H., et al. C-reactive protein concentration in children: relationship to adiposity and othercardiovascular risk factor. // Atherosclerosis. 2000. — Vol. 148. — P. 139−150
- Dao Q., Krishnaswamy P., Kazanegra R., et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. // J Am Coll Cardiol. 2001. — Vol. 37. — P. 379 385
- De Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. // N Engl J Med. 2001. — Vol. 345. — P. 1014−1021
- De Servi S., Mariani- M., Mariani G., Mazzone A. C-Reactive Protein Increase in Unstable Coronary Disease Cause or Effect? // Journal of the American College of Cardiology. 2005. — Vol. 46 (8). — P. 1001−14
- De Winter R.J. Risk stratification with cardiac troponin I in acute coronary syndromes. // J Am Coll Cardiol. 2000. — Vol. 36. — P. 18 241 826
- DeBold A., Borenstein H., Veress A., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial exrtract in rats. // Life Sci. 1981. — Vol. 28. — P. 89−94
- Douketis J.D., Crowther M.A., Stanton E.B., et al. Elevated cardiac troponin levels in patients with submassive pulmonary embolism. // Arch Intern Med. 2002. — Vol. 162. — P.79- 81
- ESC Guidelines for management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. // Eur Heart J. 2002. — Vol. 23 (23). — P. 1809−40
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. // Eur J Heart Fail. 2008. — Vol. 10 (10). — P. 933−989
- ESC Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. // Eur Heart J. 2007. — Vol. 28 (13).- P. 1598−1660
- ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Universal Definition of Myocardial Infarction. // Circulation. 2007. — Vol. 116. — P. 959−969
- Espiner E.A., Richards A.M., Yandle T.G., Nicholls M.G. Natriurethic hormones. // Endocrinol Metab Clin North Am. 1995. — Vol. 24. — P. 481−509
- Foote R.S., Peariman J.D., Siegel A.H., Yeo K.T. Detection of exercise-indiced ischemia by changes in B-type natriuretic peptides. // J Am Coll Cardiol. 2004. — Vol. 44 (10). — P. 1980−7
- Galvani M., Ottani F. and Ferrini. D., et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. // Circulation. 1997. — Vol. 95. — P. 2053−2059
- Goetze J.P., Gore A., M0ller C.H., Steinbruchel D.A., Rehfeld J.F., Nielsen L.B. Acute myocardial hypoxia increases BNP gene expression. // FASEB J. 2004. — Vol. 18(15). — P. 1928−30
- Hamm C.W., Ravkilde J., Gerhardt W., et al. The prognostic value of serum troponin T in unstable angina. // N Engl J Med. — 1992. Vol. 327.-P. 146−150
- Hudson M.P., O’Connor C.M., Gattis W.A., et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. // Am Heart J. 2004. — Vol. 147. — P. 546−552
- Ingkanisorn W.P., Rhoads K.L., Aletras A.H., Kellman P-, Arai A.E. Gadolinium delayed enhancement cardiovascular magnetic resonance' correlates with clinical measures of myocardial infarction. // J Am Coll Cardiol. -2004. Vol. 43: — P. 2253−2259
- Jackson, G., Gibbs C.R., Davies M: K., Lip G. Y. ABC of heart failure. Pathophysiology.//BMJ.-2000.-Vol. 320.-P. 167−170'
- Jackson G., Gibbs C.R., Davies M.K., Lip G.Y. ABC of heart failure. Pathophysiology. // BMJ. 2000. — Vol! 320. -P. 167−170
- James S., Armstrong P., Califf R., et al. Troponin. T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. // Am J Med. 2003. -Vol. 115.-P. 178−184
- Kangawa K., Matsuo H. Purification and complete aminoacid sequence of a-human atrial natriuretic peptide (a-hANP). // Biochem Biophys Res Commun.- 1984.-Vol. 118.-P. 131−139
- Karabinos I., Karvouni E., Chiotinis N., et al. Acute changes in N-terminal pro-brain natriuretic peptide induced by dobutamine stress echocardiography. // Eur J Echocardiogr. 2007. — Vol. 8 (4). — P. 26 574
- Katrukha A.G., Bereznikova A.V., Filatov V.L., et al. Degradation ofcardiac troponin I: implication- for reliable immunodetection. // Clin Chem. 1998. — Vol. 44 (12). — P. 2433−40
- Killip Т., Kimball J.T. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. // Am J Cardiol. -1967. Vol. 20. — P. 457−464
- Kishimoto I., Rossi K.5 Garbers D.L. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. // Proc Nat Acad Sci. -2001. Vol. 98. — P. 2703−2706
- Konstantinides S., Geibel A., Olschewski M. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. // Circulation. 1997. — Vol. 96. — P. 882−888
- Kontos M.C., Anderson F.P., Alimard R., et al. Ability of troponin I to predict cardiac events in patients admitted from the emergency department. // J Am Coll Cardial'. 2000. — Vol. 36. — P. 1818−1823
- Kontos M.C., Jesse R.L., Anderson F.P., et al. Comparison of myocardial perfusion imaging and cardiac troponin I in patients admitted to the emergency department with chest pain. // Circulation. 1999. -Vol. 99.-P. 2073−2 078 120 1
- Kragelund С., Gronning В., Omland Т., et al. Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in paients with stable coronary disease? // Am Heart J. 2006. -Vol. 151 (3). -P. 712
- Kushner I. C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging. // Cleveland Clinic Journal of Medicine: 2001. — Vol. 68 (6). — P. 535−537
- Kwan G., Isakson S. R., Beede J., Clopton P., Maisel A. S., Fitzgerald R. L. Short-Term Serial Sampling of Natriuretic Peptides in Patients Presenting With Chest Pain: // J. Am. Coll. Cardiol. 2007. — Vol. 49 (11).-P. 1186−1192
- Labugger R., Organ L., Collier C., Atar D., Van Eyk J.E. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. // Circulation. 2000. — Vol. 102 (11). — P. 12 216.
- Lee H.S., Cross S.J., Rawles J.M., et. al. Patients with suspected myocardial infarction who present with ST depression. // Lancet. -1993.-Vol. 342.-P. 1204−7
- Libby P., Ridker P.M. Novel inflammatory markers of coronary risk. // Circulation. 1999. — Vol. 100. — P. 1148−1150
- Licka M., Zimmermann R., Zehelein J., Dengler T.J., Katus H.A., Kubler W. Troponin T concentrations 72 hours after myocardial' infarction as a serological estimate of infarct size. // Heart. 2002. -Vol. 87. — P. 520−524
- Lindahl В., Venge P., Wallentin L. Relation between troponin T and therisk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. // Circulation. 1996. — Vol. 93. — P. 16 511 657
- Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. // N Engl J Med. 1994. — Vol. 331. — P. 417−24
- Lown В., Wolf M. Approaches to sudden death from coronary heart disease. // Circulation. 1971. — Vol. 44. — P. 130−142
- Magga J., Marttila M., Mantymaa P.', Vuolteenaho O., Ruskoaho H. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin-and phenylephrine-infused conscious rats. // Endocrinology. 1994: -Vol. 134 (6).-P. 2505−15
- Mahajan N., Mehta Y., Rose M., et al. Elevated troponin level is not synonymous with myocardial infarction. // Int J Cardiol'. 2006. -Vol. 111.-P. 442−449
- Matetzky S., Sharir T. and Domingo M., et al. Elevated troponin I level on admission is associated with adverse outcome of primary angioplasty in acute myocardial infarction. // Circulation. — 2000. Vol. 102. — P. 1611−1616
- Matsukawa N., Grzesik W.J., Takahashi N., et al. The natriuretic peptide clearance* receptor locally modulates the physiological effects of the natriuretic peptide system. // Proc Nat Acad Sci USA. 1999. — Vol. 96. — P. 7403−7408
- McCullough P., Nowak R., McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. // Circulation. 2002. — Vol. 106. — P. 416−420
- Mitchell A.M., Garvey J.L., Kline J.A. Multimarker panel to rule out acute coronary syndromes in low-risk patients. // Acad Emerg Med. -2006.-Vol. 13 (7).-P. 803−6
- Morita E., Yasue H., Yoshimura M. et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. // Circulation. 1993. — Vol. 88. — P. 82−91
- Morjana N.A. Degradation of human cardiac troponin I after myocardial infarction. // Biotechnol Appl Biochem. 1998. — Vol. 28. — P. 105−11
- Moitow D.A., Antman E.M., Tanasijevic M., et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. // J Am Coll Cardiol. 2000. -Vol. 36.-P. 1812−1817
- Mueller C., Buettner H.J., Hodgson J.M., et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. //
- Circulation. 2002. — Vol. 105. — P. 1412−5
- National Committee for Clinical Laboratory Standarts. Assessment of clinical Accuracy of Laboratory Tests Using Receiver Operating Characteristic (ROC) Plots Approved Guideline. NCCLS Document, GP10-A. Wayne, PA: NCCLS, 1995.
- Newby L.K., Christenson R.H., Ohman E.M., et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. // Circulation. 1998. — Vol. 98. — P. 1853−1859
- Newby L.K., Kaplan A.L., Granger B.B., et al. Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit. // Am J Cardiol. 2000. — Vol. 85. — P. 801−805
- Norgaard B.L., Andersen K., Thygesen K., et al. Longterm risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring. // Heart. -2004. Vol. 90. — P. 739−744
- Ohman E.M., Armstrong P.W., Christenson R.H., et aV. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. // N Engl J Med. 1996. — Vol. 335. — P. 1333−13 411
- Olatidoye A.G., Wu A.H.B., Feng Y.J., Waters D. Prognostic Role of Troponin T Versus Troponin T in Unstable* Angina" Pectoris for Cardiac Events With Meta- Analysis Comparing Published Studies. // Am J Cardiol. 1998. — Vol: 81. — P. 1405−1410
- Oltrona L., Ottani F., Galvani. M. Clinical significance of a single measurement of troponin-I and Creactive protein- at admission in 1773 consecutive patients with acute coronary syndromes. // Am Heart J: -2004. Vol. 148. — P. 405- 415
- Ottani F., Galvani M., Nicolini F.A., et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. // Am Heart J. 2000. — Vol. 140. — P. 917- 927
- Panteghini M., Pagani F. and Yeo K.T. et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. // Clin Chem.2004.-Vol. 50.-P. 327−332
- Pemberton C. J., Johnson M. L., Yandle T. G., E. A. Espiner. t
- Deconvolution Analysis of Cardiac Natriuretic Peptides During Acute Volume Overload. // Hypertension. 2000. — Vol. 36. — P. 355−359
- Pethig K., Heublein В., Kutschka I., Haverich A. High-sensitive C-reactive protein is associated with progressive luminal obstruction. // Circulation. 2000. — Vol. 102. — P. 233−236.
- Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. // JAMA. 2001. — Vol. 286. — P. 327−34
- Rader D.J. Inflammatory markers of coronary risk. // N. Eng. J. Med.2000.-Vol. 343.-P. 1179−1182.
- Richards A.M., Crozier I.G., Yandle T.G., et al. Brain natriuretic factor: Regional plasma concentrations and correlations with haemodynamic state in cardiac disease. // Br Heart J. 1993. — Vol. 69. — P. 414−7
- Ridker P. M'. High-sensitive C-reactive protein. Potential adjiunct for global risk assesment in the primary prevention of cardiovascular disease.//Circulation.-2001.-Vol. 103. P. 1813−1818
- Ridker P.M., Buring J.E., Shin J., et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. // Circulation. 1998. — Vol. 98. — P. 731−733
- Ridker P.M., Cushman M., Stampfer M: J., Tracy R.P., Hennekens G.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. // N Engl J Med. 1997. — Vol. 336. — P. 973−9
- Ridker P.M., Hennekens C.H., Rifai N., Buring J.E., Manson J.E. Hormone replacement therapy and increased plasma concentration of C-reactive protein: // Circulation. 1999. — Vol. 100. — P. 713−6
- Sanchez P. L., Rodriguez M! V., Villacort E., Albarran C., Cruz Г., Moreiras J. Mt, MartinF., Pabon P., et al. Kinetics of C-Reactive Protein Release in Different Forms of Acute Coronary Syndrome. // Rev Esp Cardiol. 2006. — Vol. 59(5). — P. 441−7
- Savonitto S., Ardissino D., Granger C.B., et al. Prognostic value of admission electrocardiogram in acute coronary syndromes. // JAMA. -1999. Vol. 281(8). — P. 707−13
- Showalter C.J., Zimmerman R.S., Schwab T.R., et al. Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II. // Am J Physiol. 1988. — Vol: 254. — P. 453−456
- Talwar S., Squire I.B., Downie P.F., et al. Profile of plasma N-terminal proBNP following acute myocardial infarction- correlation with left ventricular systolic dysfunction. // Eur Heart J. 2000. — Vol. 21. — P. 1514−1521
- Tamura N., Ogawa Y., Yasoda A. Two cardiac natriuretic peptide genesatrial natriuretic peptide and-brain natriuretic peptide)8 are organized in tandem m the mouse and human genomes. // J Mol Cell Cardiol. 1996. -Vol. 28.-P. 1811−1885
- Tanaka A., Shimada K., Sano Т., et al. Multiple Plaque Rupture and C-Reactive Protein m Acute Myocardial Infarction. // J Am Coll Cardiol. -2005.-Vol. 45.-P. 1594−9
- Toss H., Lindahl В., Siegbahn A., Wallentin L. for the FRISC Study Group. Prognostic influence of increased fibrinogen and4 C-reactive protein levels in unstable coronary artery disease. // Circulation. 1997. -Vol. 96.-P. 4204−10
- Tracy R.P., Lemaitre R.N., Psaty B. M-, et al. Relationship study of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion
- Project. // Atherosclerosis Tromb. Vase. Biol. 1997. — Vol. 17. — P. 1121−1127
- Tsutamoto Т., Kanamory Т., Morigami N., et al. Possibility of downregulation of atrial natriureric peptide receptor coupled to guanylate in peripheral beds of patients with chronic severe heart failure. // Circulation. 1993. — Vol. 87. — P. 70−75
- Vanderheyden M., Bartunek J., Goethals M. Brain and other natriuretic peptides: molecular aspects. // Eur J Heart Failure. 2004. — Vol. 6. — P. 261−268'
- Visser M., Bouter L.M., McQuillan G.M., Wener M.H., Harris T.B. Elevated C-reactive protein levels in. overweight and obese adults. // JAMA. 1999. — Vol. 282. — P. 2131−5
- Wallace T.W., Abdullah S.M., Drazner M.H., et al. Prevalence and determinants of troponin T elevation in the general population. // Circulation. 2006. — Vol. 113. — P. 1958−1965
- Weber M., Dill' Т., Arnold R., et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. // Am Heart J. 2004. — Vol. 148 (4).-P. 612−20
- Weber M'., Kleine C., Keil E., Rau M., Berkowitsch A., Elsaesser A., Mitrovic V., Hamm C. Release pattern of N-terminal pro B-type natriuretic peptide in acute coronary syndromes. // Clin Res Cardiol. -2006. Vol. 95(5). — P. 270−80
- Westerhout C.M., Fu Y., Lauer M.S., et al. Short- and long-term risk stratification in acute coronary syndromes: The added value of quantitative ST-segment depression and multiple biomarkers. // J Am Coll Cardiol. 2006. — Vol. 48. — P. 939−47
- Wolber Т., Maeder M., Rickli H., et al. N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis. // Eur J Clin Invest. 2007. — Vol. 37 (1). — P. 18−25ь
- Zairis M.N., Papadaki O.A., Manousakis S.J., et al. C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina. // Atherosclerosis. 2002. — Vol. 164. — P. 355−9